Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer

Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer

Serial assessment of Karnofsky performance status (KPS), the Thai modified Functional Living Index Cancer (T-FLIC) and the Thai modified Quality of Life Index (T-QLI) have been used to estimate the quality of life of advanced non-small cell lung cancer patients. This is a prospective randomized tria...

Saved in:

書目詳細資料
Main Authors:	Thongprasert S., Sanquanmitr P.
格式:	Clinical Trial
語言:	English
出版:	2014
在線閱讀:	http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3469
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Reliability of the Thai-Modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients
由: Thongprasert S., et al.
出版: (2014)

Reliability of the Thai-Modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients
由: Sumitra Thongprasert, et al.
出版: (2018)

Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients
由: Sorraritchingchai S., et al.
出版: (2014)

Lung cancer and quality of life
由: Thongprasert S.
出版: (2014)

A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer
由: Sumitra Thongprasert, et al.
出版: (2018)

Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Symptom clusters in Thai patients with advanced lung cancer
由: Noppamat Pudtong
出版: (2013)

Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective
由: Thongprasert,S., et al.
出版: (2015)

Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective
由: Thongprasert S., et al.
出版: (2014)

Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer
由: Thongprasert S.
出版: (2014)

Measuring quality of life in Chinese cancer patients: A new version of the Functional Living Index for Cancer (Chinese)
由: Cheung, YB, et al.
出版: (2023)

Modifiable Factors and Colon Cancer Risk in Thai Population
由: Suthat Chottanapund, et al.
出版: (2022)

Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer
由: Thongprasert S., et al.
出版: (2014)

Effects of paclitaxel and carboplatin on quality of life and survival in patients with advanced non-small-cell lung cancer
由: Vorachai Ratanatharathorn, et al.
出版: (2018)

Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy
由: Thongprasert S., et al.
出版: (2014)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Thongprasert S., et al.
出版: (2017)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
由: Akhtari, M, et al.
出版: (2020)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Charoentum C., et al.
出版: (2014)

Thai experience in lung cancer treatment
由: T. Limsila
出版: (2018)

Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
由: Chaiyut Charoentum, et al.
出版: (2018)

THE DESCRIPTION OF SMOKING DEGREE BASED ON BRINKMAN INDEX IN PATIENTS WITH LUNG CANCER
由: DESSY ARUMSARI, 101511133061, et al.

The functional living index-cancer is a reliable and valid instrument in Chinese cancer patients
由: Fong, D.Y.T., et al.
出版: (2014)

Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer
由: Thongprasert S.
出版: (2014)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Charoentum C., et al.
出版: (2014)

Lung cancer: Recent advances
由: Lee, P.
出版: (2016)

Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer
由: Thongprasert S.
出版: (2014)

Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand
由: Kitiporn Srisam-ang, et al.
出版: (2018)

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
由: Chaiyut Charoentum, et al.
出版: (2018)

Validity and Reliability of the Thai version of the Family Dermatology Life Quality Index
由: Kulthanan K.
出版: (2023)

p53 gene mutations in non-small cell lung cancer from Thai patients
由: Songsak Petmitr, et al.
出版: (2018)

Validation of a modified Thai version of the Western Ontario and McMaster (WOMAC) osteoarthritis index for knee osteoarthritis
由: Vilai Kuptniratsaikul, et al.
出版: (2018)

Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer
由: Chewaskulyong B., et al.
出版: (2014)

Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC)
由: Thongprasert S., et al.
出版: (2014)

Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital
由: Thongprasert S.
出版: (2014)

The validity and reliability of the thai version of children’s dermatology life quality index (CDLQI)
由: Wanee Wisuthsarewong, et al.
出版: (2018)

Dermatology Life Quality Index in Thai Patients with Facial Port-Wine Stains
由: Jantarakolica T.
出版: (2023)